The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing
about
sameAs
Molecular and therapeutic potential and toxicity of valproic acidCleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme AAn epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.Diet and the epigenetic (re)programming of phenotypic differences in behaviorEnvironmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genomeProtein Phosphatase 2A as a Therapeutic Target in Acute Myeloid LeukemiaNeurological and Epigenetic Implications of Nutritional Deficiencies on Psychopathology: Conceptualization and Review of EvidenceApplicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyDNA demethylation and invasive cancer: implications for therapeuticsColorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in cultureArsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET proteinA Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma CellsThe methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptorThe Integration of Genetic Propensities into Social-Control Models of Delinquency and Violence among Male YouthsProteomic analysis of SET-binding proteins.A method for purification, identification and validation of DNMT1 mRNA binding proteinsMutations in genes involved in nonsense mediated decay ameliorate the phenotype of sel-12 mutants with amber stop mutations in Caenorhabditis elegansRegulating Set-β's Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration.Epigenetics, behaviour, and health.The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylationCloning, purification, crystallization and preliminary X-ray crystallographic analysis of SET/TAF-Iß δN from Homo sapiens.Promoter-specific activation and demethylation by MBD2/demethylase.The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes.Human factors and pathways essential for mediating epigenetic gene silencing.BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Environmental regulation of the neural epigenome.Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.pp32 reduction induces differentiation of TSU-Pr1 cells.A role for poly(ADP-ribosyl)ation in DNA methylation.The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments.DNA methylation, the early-life social environment and behavioral disordersThe N-terminal Set-β Protein Isoform Induces Neuronal DeathSET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice.Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia.5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer.Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.Nuclear mechanics in cancerDynamic and reversibility of heterochromatic gene silencing in human disease.Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes.Therapeutic implications of DNA methylation.
P2860
Q21296867-E0FD963E-450E-4A71-9DE0-691319876DA3Q24338600-EE4A9B1C-3EC6-464D-A74A-343A0ADBA2EFQ24544035-CE2B86F7-7199-412C-A3B9-AAD34015ADBFQ24634401-2A643046-EC4B-4548-879B-F6E045EAFD7CQ24635630-8E8CCAAB-48C1-4FE0-91B1-662087184402Q26752430-BCC8F99C-A324-46C8-8A33-8C5095814978Q26801187-2BFD6E0F-76C1-47A7-A607-EE94BC726FF8Q26864605-632D2795-73BD-4108-824E-977E98ECDBD6Q27011914-202ED75A-DE48-4D75-93A1-EE2950E089DAQ28391219-A4B5479E-5163-498C-B215-64F0CE9D7E89Q28538642-249BCC77-7CC4-4DA1-8110-8322C8EABA71Q28551285-427DD3A1-4918-4764-8FF1-AFF46D058FE7Q28571655-F692F41C-2A36-4205-B857-835E117DF390Q29999389-21A92EB4-15D8-4B08-B1A1-7388C3581500Q33274521-99052A07-82B3-4EEB-AC60-8DB91171A6A2Q33388710-100D9FFF-381B-42B9-9ECD-45F0F2F37E72Q33420094-AF962245-0B64-438B-88BF-E0D221A6296AQ33639540-80E0D1B6-352C-45CB-B5A2-3FB8046692FEQ33848607-463D079C-9375-497A-A314-1D52FA8B1170Q34025643-76D4EF6A-ED8B-4D0F-B1FC-0A10E296DC60Q34049166-D31FADB4-38F6-4E6D-AA0C-5F08314137ECQ34144453-0CC76D9A-DA08-446C-947C-84DC87FDA229Q34180593-C7F9EF51-EED1-400D-AFB9-6E3D389E15D6Q34212695-D80C2B2A-4913-4396-B006-A2971F9B1612Q34541748-8864E257-B3FA-4F63-8914-58D9D0E94A14Q34627769-31E70C94-5D63-44E2-89D3-06896AC2ECB3Q35057121-29B00201-4CC5-428D-8825-BA2D5FACBFA1Q35083306-5090DB2C-405E-48AB-9BE2-057B64B1A3BFQ35191562-768FD3E2-BA19-4E83-8B51-37CE1C598136Q35252961-B68D3C50-31F6-4D60-AA67-298CD2287770Q35680703-251A4D63-5A14-4BFF-895F-7EB186ECD195Q35861000-703FE4C2-D9A1-4592-AA51-CD9EFB992DC5Q35915972-093FE47D-6AE1-4090-93A7-6C20BE0771CDQ35944719-6DB92BAF-FFCE-4190-9B60-223CA9626401Q36002451-BEC0985B-2022-4F64-B566-8EF3C770B6DEQ36020877-0040C5BA-DE35-40FF-9610-0D81056F0E7EQ36116300-750C81B9-6C73-4AA2-BDAC-9014F2F141A9Q36280490-DC4EFDE4-E5F7-4B84-9277-0BB51AFB27EEQ36315629-39FB6492-CE9E-4466-ACF6-B44884DD8CDDQ36429409-21E4736E-1C62-4A9D-9889-9EE60BC0E94F
P2860
The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@ast
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@en
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@nl
type
label
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@ast
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@en
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@nl
prefLabel
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@ast
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@en
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@nl
P2093
P2860
P3181
P356
P1476
The oncoprotein Set/TAF-1beta, ...... and transcriptional silencing
@en
P2093
Debabrata Chakravarti
Nadia Cervoni
Nancy Detich
Sang-Beom Seo
P2860
P304
P3181
P356
10.1074/JBC.M202256200
P407
P50
P577
2002-07-12T00:00:00Z